TB patients will not be denied treatment on basis of domicile: Government Industry-The Economic Times — January 21, 2017 comments off In December 2016, the father of an 18-year-old patient suffering from XDR TB took National Institute of Tuberculosis and Respiratory Diseases to court because the hospital refused access to the new drug, Bedaquiline.